Syphilis screening (CSF VDRL)
Starts at ₱ 5,200
The Syphilis screening (CSF VDRL) test is a laboratory test used to detect the presence of antibodies against Treponema pallidum, the bacterium responsible for syphilis, in the cerebrospinal fluid (CSF). The test is performed by collecting a sample of CSF through a lumbar puncture (spinal tap), and then analyzing it for signs of infection. The Syphilis screening (CSF VDRL) test is primarily used to diagnose neurosyphilis, a condition where syphilis affects the nervous system, which can occur in untreated or late-stage syphilis. It is typically administered when a patient shows symptoms of neurosyphilis, such as cognitive changes, meningitis, or abnormal behavior, or in cases where there is a suspicion of syphilis affecting the central nervous system. The test is also used to monitor treatment efficacy in patients diagnosed with neurosyphilis.
Participating Providers
Tests Included
Syphilis screening (CSF VDRL)
Test Requirements
How to Claim
FREE Hati Health Concierge Service
Hassle-Free Testing with Hati Health
Easy Appointment Booking
Clear & Fixed Pricing
Curated Plans For Your Needs
Related Products
Related Categories
More About This Product
Find best Syphilis screening (CSF VDRL) price. The Syphilis screening (CSF VDRL) test is a crucial laboratory test designed to identify the presence of antibodies against Treponema pallidum, the bacterium responsible for syphilis, in the cerebrospinal fluid (CSF). This test is performed through a procedure called lumbar puncture, or spinal tap, where a sample of CSF is collected and analyzed to detect signs of infection. It is primarily utilized for diagnosing neurosyphilis, a serious condition where syphilis has impacted the nervous system, which can occur in late-stage or untreated cases of the disease. Typical symptoms indicating the need for this test include cognitive changes, signs of meningitis, dizziness, muscle stiffness, or abnormal behavior, as well as situations where neurosyphilis is suspected. Additionally, this test is vital for monitoring the effectiveness of treatment in patients already diagnosed with neurosyphilis. Understanding and early detection through the Syphilis screening (CSF VDRL) can make a significant difference in treatment outcomes.